C4830
Calcium carbonate
BioXtra, ≥99.0%
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CaCO3
CAS Number:
Molecular Weight:
100.09
UNSPSC Code:
12161700
NACRES:
NA.25
PubChem Substance ID:
EC Number:
207-439-9
Beilstein/REAXYS Number:
8008338
MDL number:
product line
BioXtra
Quality Level
assay
≥99.0%
form
powder
impurities
≤0.002% Phosphorus (P), ≤0.1% Insoluble matter
solubility
H2O: insoluble
density
2.93 g/mL at 25 °C (lit.)
anion traces
chloride (Cl-): ≤0.005%, sulfate (SO42-): ≤0.005%
cation traces
Al: ≤0.0005%, Ba: ≤0.005%, Cu: ≤0.0005%, Fe: ≤0.002%, K: ≤0.005%, Mg: ≤0.01%, NH4+: ≤0.05%, Na: ≤0.005%, Pb: ≤0.001%, Sr: ≤0.1%, Zn: ≤0.0005%
SMILES string
[Ca++].[O-]C([O-])=O
InChI
1S/CH2O3.Ca/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2
InChI key
VTYYLEPIZMXCLO-UHFFFAOYSA-L
Still not finding the right product?
Explore all of our products under Calcium carbonate
Storage Class
13 - Non Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jane A Cauley et al.
Journal of women's health (2002), 22(11), 915-929 (2013-10-18)
Clinical outcomes of the Women's Health Initiative (WHI) calcium plus vitamin D supplementation trial have been reported during 7.0 years of active intervention. We now report outcomes 4.9 years after the intervention stopped and cumulative findings. Postmenopausal women (N=36,282) were
M Azizur Rahman et al.
PloS one, 8(3), e58781-e58781 (2013-03-26)
An organic matrix consisting of a protein-polysaccharide complex is generally accepted as an important medium for the calcification process. While the role this "calcified organic matrix" plays in the calcification process has long been appreciated, the complex mixture of proteins
Sophie A Jamal et al.
Lancet (London, England), 382(9900), 1268-1277 (2013-07-23)
Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of